Viewing Study NCT06042894


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-31 @ 7:22 PM
Study NCT ID: NCT06042894
Status: RECRUITING
Last Update Posted: 2025-09-26
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER-2 negative View